Searched for
ARAGEN DRUG COMPANY
From OYO's Ritesh Agarwal to BlissClub's Minu Margaret: Check out 155 entrepreneurs in Hurun India's under-35 listAvendus Wealth and Hurun India have unveiled the U35 List, celebrating 155 exceptional young leaders under 35. These entrepreneurs are driv...- Avendus Fund, SBI Life lead funding in AragenAvendus Future Leaders Fund and SBI Life Insurance have collectively invested ₹300 crore in Aragen Life Sciences, acquiring a 2.5% stake in...
- India's contract drug makers seek government support in China fightIndia's contract drug makers are seeking government support to remove regulatory hurdles and speed up raw material import clearances. With ...
- Quadria Capital to pick up minority stake in drug company AragenQuadria Capital is set to acquire a 10% stake in Aragen Life Sciences for about $100 million, valuing the Indian CRDMO at $1.2 billion. The...
- Goldman-backed Aragen eyes Rs 12,000 crore as pre-IPO dose; Novo Nordisk keenInvestors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a minority stake and ...
- Indian drug manufacturers benefit from Big Pharma interest beyond ChinaChina has for nearly 20 years been the preferred location for a range of pharmaceutical research and manufacturing services due to the low ...
- CRO market still very much untapped in India: Cyndrella CarvalhoIndian CROs and CDMOs are attracting a lot of attention as companies, such as Syngene, Suven, and Divis, create long-term relationships wit...
- Goldman Sachs buys stake in contract research firm Aragen Life SciencesAragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platform...
- Goldman Sachs set to buy 33% stake in GVK Bio at Rs 7,300-crore valuationThe other contenders included Carlyle Group, Warburg Pincus, General Atlantic and Quadria Capital, as well as Singapore’s Temasek Holdings.
- Global PE funds eye stake in GVK Bio, co valued at $800 mnIn this proposed transaction, GVK BIO- promoted by the GVK Group and DS Brar, the former CEO and managing director of Ranbaxy Laboratories,...
- GVK Biosciences plans Rs 100 crore active pharmaceutical ingredients facilityGVK Biosciences proposes to set up active pharmaceutical ingredients (APIs) manufacturing facility to cater to the needs of its existing an...
Load More
